← Leaderboards
Catherine L Clelland
Mount Sinai School Of Medicine Of Nyu
$7,598,878
Attributed
$7,598,878
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,598,878 · 11
By mechanism
R01$3,439,444 · 2
R21$2,421,503 · 6
RF1$1,725,811 · 1
M01$12,120 · 2
Top collaborators
No co-investigators on record.
Most similar at Mount Sinai School Of Medicine Of Nyu
Same institution · by research overlap
- Robert F Margolskee$16,803,321
Others in their field
Top investigators on “Reporting”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$564,567,727
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Bambra Strokes · Ppd Development Lp$461,655,950
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ReportingPharmaceutical PreparationsExhibitsGenesPlasmaDopamineGlutamatesAlzheimer&AposSchizophreniaNeurotransmittersEnzymesBrainSamplingPhenotypePeripheralImpaired CognitionBehavioralBloodAmino AcidsNeuromodulatorProlineFastingCognitive DeficitsLearning
Grant awards (22)
Tetrahydrobiopterin Effects on Cognitive Function in Alzheimer's Disease: Biochemical, Molecular and Cognitive Analysis$575,612
R01 · FY2025 · AG · contact PI
Tetrahydrobiopterin Effects on Cognitive Function in Alzheimer's Disease: Biochemical, Molecular and Cognitive Analysis$714,890
R01 · FY2024 · AG · contact PI
Tetrahydrobiopterin Effects on Cognitive Function in Alzheimer's Disease: Biochemical, Molecular and Cognitive Analysis$1,725,811
RF1 · FY2021 · AG · contact PI
A Novel Personalized Approach Towards Treating Negative Symptoms and Reducing Alcohol Abuse in patients with Comorbid AUD and Schizophrenia.$201,085
R21 · FY2020 · AA · contact PI
A Novel Personalized Approach Towards Treating Negative Symptoms and Reducing Alcohol Abuse in patients with Comorbid AUD and Schizophrenia.$266,464
R21 · FY2019 · AA · contact PI
Apathy in Alzheimer's Disease: Investigation of the Interaction between Proline and COMT for Treatment Targeting to Positively Impact Quality of Life$243,000
R21 · FY2019 · AG · contact PI
Negative Symptoms in Clinical High Risk and First Episode Psychiatric Illness: Investigation of a New Candidate for Targeted Treatment.$242,875
R21 · FY2019 · MH · contact PI
Vitamin-D- PRODH- & DTNBP1-Induced Hyperprolinemia:Schizophrenia Risk & Treatment$325,998
R01 · FY2018 · MH · contact PI
Negative Symptoms in Clinical High Risk and First Episode Psychiatric Illness: Investigation of a New Candidate for Targeted Treatment.$217,878
R21 · FY2018 · MH · contact PI
Apathy in Alzheimer's Disease: Investigation of the Interaction between Proline and COMT for Treatment Targeting to Positively Impact Quality of Life$202,500
R21 · FY2018 · AG · contact PI
Vitamin-D- PRODH- & DTNBP1-Induced Hyperprolinemia:Schizophrenia Risk & Treatment$437,926
R01 · FY2017 · MH · contact PI
Vitamin-D- PRODH- & DTNBP1-Induced Hyperprolinemia:Schizophrenia Risk & Treatment$441,837
R01 · FY2016 · MH · contact PI
Vitamin-D- PRODH- & DTNBP1-Induced Hyperprolinemia:Schizophrenia Risk & Treatment$438,534
R01 · FY2015 · MH · contact PI
Vitamin-D- PRODH- & DTNBP1-Induced Hyperprolinemia:Schizophrenia Risk & Treatment$504,647
R01 · FY2014 · MH · contact PI
Temporal Changes in MicroRNA Function During Tau tangle Accumulation$164,426
R21 · FY2011 · AG · contact PI
Temporal Changes in MicroRNA Function During Tau tangle Accumulation$205,275
R21 · FY2010 · AG · contact PI
PROSTATE TUMOR DIAGNOSIS: BLOOD CELL MULTIGENE SIGNATURES$7,294
M01 · FY2007 · RR · contact PI
PROSTATE TUMOR DIAGNOSIS: BLOOD CELL MULTIGENE SIGNATURES$4,826
M01 · FY2006 · RR · contact PI
Breast Cancer Diagnosis: Blood-Cell Multigene Signatures$169,500
R21 · FY2004 · CA
Prostate Tumor Diagnosis:Blood Cell Multigene Signatures$169,500
R21 · FY2004 · CA
Breast Cancer Diagnosis: Blood-Cell Multigene Signatures$169,500
R21 · FY2003 · CA
Prostate Tumor Diagnosis:Blood Cell Multigene Signatures$169,500
R21 · FY2003 · CA